TTK Healthcare Ltd. Stock Falls to 52-Week Low of Rs.932.2

Stock Price Movement and Market Context

On 11 Feb 2026, TTK Healthcare’s share price reached Rs.932.2, the lowest level recorded in the past year. This decline comes despite the stock posting a modest 1.27% gain over the last two trading sessions. However, the stock continues to trade below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained downward momentum.

In comparison, the Nifty index closed at 25,953.85, up 0.07% on the day, and remains just 1.62% shy of its 52-week high of 26,373.20. The broader market has been on a positive trajectory, with the Nifty enjoying a three-week consecutive rise, gaining 3.61% over this period. Large-cap stocks have led this rally, with the Nifty Next 50 index up 0.55%. This divergence highlights TTK Healthcare’s relative underperformance within the current market environment.

Long-Term Performance and Sector Comparison

Over the past year, TTK Healthcare has delivered a negative return of -21.97%, significantly lagging behind the Sensex, which has appreciated by 10.41% during the same period. The stock’s 52-week high was Rs.1,402, indicating a substantial decline of approximately 33.5% from that peak.

Within the diversified sector, the stock’s performance has been below par, underperforming the BSE500 index across multiple time frames including the last three years, one year, and three months. This persistent lag reflects challenges in maintaining growth momentum relative to peers and the broader market.

Financial Metrics and Growth Trends

TTK Healthcare’s long-term growth metrics reveal subdued expansion. Net sales have increased at an annualised rate of 6.99% over the last five years, while operating profit has grown at 15.42% annually during the same period. These figures suggest moderate growth but fall short of robust sector benchmarks.

Recent quarterly results have been largely flat, with non-operating income constituting a significant 80.43% of profit before tax (PBT), indicating limited contribution from core business operations. The company’s cash and cash equivalents stood at Rs.600.89 crores in the half-year period, the lowest level recorded recently, while the debtors turnover ratio was 7.40 times, also at a low point.

Shareholding and Market Perception

Despite its size, TTK Healthcare commands a minimal stake from domestic mutual funds, holding only 0.01% of the company’s shares. Given that domestic mutual funds typically conduct thorough research and maintain significant positions in companies they favour, this small holding may reflect a cautious stance towards the stock’s valuation or business prospects.

Valuation and Profitability Indicators

The company maintains a low average debt-to-equity ratio of zero, reflecting a conservative capital structure. Return on equity (ROE) stands at 6.5%, which is modest but indicates some level of profitability. The stock trades at a price-to-book value of 1.3, suggesting a premium valuation relative to book value.

However, the price-to-earnings-to-growth (PEG) ratio is elevated at 8.3, signalling that the stock’s price may not be fully justified by its earnings growth, which has risen by only 2.4% over the past year. This disparity between valuation and growth metrics may contribute to the subdued market sentiment.

Mojo Score and Rating Update

TTK Healthcare currently holds a Mojo Score of 37.0, with a Mojo Grade of Sell, downgraded from Hold on 21 Jul 2025. This rating reflects the stock’s recent performance trends and financial metrics, signalling caution in the current market environment.

The company’s market capitalisation grade is 4, indicating a micro-cap status within the diversified sector. The stock underperformed its sector by 0.7% on the day it hit the 52-week low, further underscoring its relative weakness.

Summary of Key Concerns

TTK Healthcare’s stock has been weighed down by a combination of factors including subdued long-term growth rates, flat recent results, and a valuation premium not fully supported by earnings growth. The limited interest from domestic mutual funds and the stock’s position below all major moving averages add to the cautious outlook reflected in its recent price action.

While the company maintains a conservative debt profile and modest profitability, these positives have not translated into sustained market confidence, as evidenced by the stock’s 52-week low and underperformance relative to benchmarks.

Market and Sector Overview

The broader market environment remains positive, with the Nifty index and all market capitalisation segments posting gains. Large-cap stocks have led the rally, contrasting with the performance of smaller diversified stocks such as TTK Healthcare. This divergence highlights the challenges faced by certain micro-cap stocks in capturing investor attention amid a bullish market backdrop.

Conclusion

TTK Healthcare Ltd.’s recent fall to Rs.932.2 marks a notable low point for the stock within the last year. The combination of modest growth, flat recent earnings, and valuation concerns has contributed to this decline. Despite a stable capital structure and some profitability, the stock’s relative underperformance and cautious market perception remain key factors shaping its current valuation.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →